These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18803910)

  • 1. Use of animal models to develop antiaddiction medications.
    Gardner EL
    Curr Psychiatry Rep; 2008 Oct; 10(5):377-84. PubMed ID: 18803910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction.
    Xi ZX; Gardner EL
    CNS Drug Rev; 2007; 13(2):240-59. PubMed ID: 17627675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
    Heidbreder C
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.
    Heidbreder CA; Newman AH
    Ann N Y Acad Sci; 2010 Feb; 1187():4-34. PubMed ID: 20201845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral perspectives on the neuroscience of drug addiction.
    Winger G; Woods JH; Galuska CM; Wade-Galuska T
    J Exp Anal Behav; 2005 Nov; 84(3):667-81. PubMed ID: 16596985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.
    Heidbreder CA; Gardner EL; Xi ZX; Thanos PK; Mugnaini M; Hagan JJ; Ashby CR
    Brain Res Brain Res Rev; 2005 Jul; 49(1):77-105. PubMed ID: 15960988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine D3 receptor, a quarter century later.
    Sokoloff P; Le Foll B
    Eur J Neurosci; 2017 Jan; 45(1):2-19. PubMed ID: 27600596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction.
    Filip M; Alenina N; Bader M; Przegaliński E
    Addict Biol; 2010 Jul; 15(3):227-49. PubMed ID: 20456287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
    Gyertyán I; Gál K
    Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychology and neurobiology of addiction: an incentive-sensitization view.
    Robinson TE; Berridge KC
    Addiction; 2000 Aug; 95 Suppl 2():S91-117. PubMed ID: 11002906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacology of cocaine and ethanol dependence.
    Koob GF; Weiss F
    Recent Dev Alcohol; 1992; 10():201-33. PubMed ID: 1350359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 receptor antagonists: a patent review (2007 - 2012).
    Micheli F; Heidbreder C
    Expert Opin Ther Pat; 2013 Mar; 23(3):363-81. PubMed ID: 23282131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.
    Heidbreder C
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):167-76. PubMed ID: 23104235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.
    Vorel SR; Ashby CR; Paul M; Liu X; Hayes R; Hagan JJ; Middlemiss DN; Stemp G; Gardner EL
    J Neurosci; 2002 Nov; 22(21):9595-603. PubMed ID: 12417684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction: 4 big questions.
    Holmes D
    Nature; 2015 Jun; 522(7557):S63. PubMed ID: 26107101
    [No Abstract]   [Full Text] [Related]  

  • 17. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stress in addiction relapse.
    Sinha R
    Curr Psychiatry Rep; 2007 Oct; 9(5):388-95. PubMed ID: 17915078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.